March 31, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walker & Dunlop, Inc. (“Walker & Dunlop” or “the Company”) (NYSE: WD). Investors who purchased Walker & Dunlop securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
March 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of On Holding AG (“On” or “the Company”) (NYSE: ONON). Investors who purchased On securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether On has violated… read more
March 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Weis Markets, Inc. (“Weis Markets” or “the Company”) (NYSE: WMK). Investors who purchased Weis Markets securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Weis… read more
March 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vertical Aerospace Ltd. (“Vertical Aerospace” or “the Company”) (NYSE: EVTL). Investors who purchased Vertical Aerospace securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Vertical… read more
March 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Yiren Digital Ltd. (“Yiren” or “the Company”) (NYSE: YRD). Investors who purchased Yiren securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Yiren has violated… read more
March 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Yiren Digital Ltd. (“Yiren” or “the Company”) (NYSE: YRD). Investors who purchased Yiren securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Yiren has violated… read more
March 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Yiren Digital Ltd. (“Yiren” or “the Company”) (NYSE: YRD). Investors who purchased Yiren securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Yiren has violated… read more
March 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Yiren Digital Ltd. (“Yiren” or “the Company”) (NYSE: YRD). Investors who purchased Yiren securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Yiren has violated… read more
March 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ePlus, inc. (“ePlus” or “the Company”) (NASDAQ: PLUS). Investors who purchased ePlus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ePlus has violated federal… read more
March 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ePlus, inc. (“ePlus” or “the Company”) (NASDAQ: PLUS). Investors who purchased ePlus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ePlus has violated federal… read more
March 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BellRing Brands, Inc. (“BellRing” or “the Company”) (NYSE: BRBR). Investors who purchased BellRing securities prior to November 19, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BellRing Brands, Inc. (“BellRing” or “the Company”) (NYSE: BRBR). Investors who purchased BellRing securities prior to November 19, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Anavex Life Sciences Corp. (“Anavex” or “the Company”) (NASDAQ: AVXL). Investors who purchased Anavex securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Anavex has… read more
March 25, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Vita Coco Company, Inc. (“Vita Coco” or “the Company”) (NASDAQ: COCO). Investors who purchased Vita Coco securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
March 24, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
March 24, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
March 24, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
March 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nuvation Bio Inc. (“Nuvation” or “the Company”) (NYSE: NUVB). Investors who purchased Nuvation securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nuvation has violated… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Xponential Fitness, Inc. (“Xponential” or “the Company”) (NYSE: XPOF). Investors who purchased Xponential securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Xponential has violated… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aardvark Therapeutics, Inc. (“Aardvark” or “the Company”) (NASDAQ: AARD). Investors who purchased Aardvark securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Aardvark has violated… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between KORE Group Holdings, Inc. (“KORE”) (NYSE: KORE) and Searchlight Capital Partners and Abry Partners (“Searchlight and Abry”). Investors who purchased KORE and continue to hold to the present are encouraged to obtain additional information and… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sunrun Inc. (“Sunrun” or “the Company”) (NASDAQ: RUN). Investors who purchased Sunrun securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sunrun has violated federal… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Disc Medicine, Inc. (“Disc Medicine” or “the Company”) (NASDAQ: IRON). Investors who purchased Disc Medicine securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Disc… read more
March 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Freshpet, Inc. (“Freshpet” or “the Company”) (NASDAQ: FRPT). Investors who purchased Freshpet securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Freshpet has violated federal… read more
March 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TruBridge, Inc. (“TruBridge” or “the Company”) (NASDAQ: TBRG). Investors who purchased TruBridge securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TruBridge has violated federal… read more
March 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OneMain Holdings, Inc. (“OneMain” or “the Company”) (NYSE: OMF). Investors who purchased OneMain securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether OneMain has violated… read more
March 18, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medical Properties Trust, Inc. (“Medical Properties” or “the Company”) (NYSE: MPT). Investors who purchased Medical Properties securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
March 18, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of IperionX Limited (“IperionX” or “the Company”) (NASDAQ: IPX). Investors who purchased IperionX securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether IperionX has violated federal… read more
March 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arq, Inc. (“Arq” or “the Company”) (NASDAQ: ARQ). Investors who purchased Arq securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Arq has violated federal… read more
March 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Victoria’s Secret & Co. (“Victoria’s Secret” or “the Company”) (NYSE: VSCO). Investors who purchased Victoria’s Secret securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more